A clinical trial to study the preventive effect of zoledronic acid therapy on drug induced bone loss in breast cancer
Not Applicable
Completed
- Conditions
- Health Condition 1: null- postmenopausal hormone receptor positive early breast cancer (stage I-IIIA) patients, who had had primary surgery, did not have recurrent or metastatic disease treated with aromatase inhibitor
- Registration Number
- CTRI/2014/09/004943
- Lead Sponsor
- Dr Ved Prakash
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
postmenopausal hormone receptor positive early breast cancer (stage I-IIIA) patients, who had had primary surgery, did not have recurrent or metastatic disease and treated with aromatase inhibitor
Exclusion Criteria
Male
Premenopausal
Advanced disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method